Method of treating cancer associated with a RAS mutation
AssigneeBeyondSpring Pharmaceuticals, Inc.
InventorLan Huang
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of treating a cancer characterized by expressing a mutant form of a RAS protein. Some embodiments relate to treatment of cancer by administering Plinabulin to a subject in need thereof.
Claims24
A method of therapeutically treating a cancer characterized by expressing a mutant form of a RAS protein, comprising administering Plinabulin to a subject in need thereof.
A method of inhibiting proliferation of a cell having a RAS mutation, comprising contacting the cell with Plinabulin.
A method of inhibiting progression of a cancer characterized by expressing a mutant form of a RAS protein in a subject, comprising administering Plinabulin to a subject in need thereof.
Dependencies are inferred from the claim text.